HCW Biologics HCWB
NASDAQ HCWB
$1.69 -0.02 (-1.17%)
At close: Oct 1, 2026 · 4:00 PM EDT

HCW Biologics (HCWB) Other Non-Current Liabilities (2022 - 2026)

Updated

HCW Biologics (HCWB) reported Other Non-Current Liabilities of $692,531 for Q2 2026, down 60.4% from $1.75 million a year earlier.

Analysis

HCW Biologics (HCWB) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Dating back to Q1 2022, HCW Biologics' Other Non-Current Liabilities record includes 10 quarters.

  • Other Non-Current Liabilities has a three-year compound annual growth rate of 264.7% (FY2022 to FY2025).
  • By year, Other Non-Current Liabilities came in at $14,275 in FY2022.
  • Five-year quarterly Other Non-Current Liabilities spans a low of $7,476 in Q1 2023 and a high of $1.75 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 HCW Biologics 2.27 Mn -3.96 Mn -93,887.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 692,531.00
Dec 31, 2025 692,531.00
Sep 30, 2025 692,531.00
Jun 30, 2025 1.75 Mn
Mar 31, 2025 54,000.00
Mar 31, 2023 7,476.00
Dec 31, 2022 14,275.00
Sep 30, 2022 56,676.00
Jun 30, 2022 98,447.00
Mar 31, 2022 139,597.00
API Access

HCW Biologics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=HCWB&period=max&api_key=YOUR_API_KEY